Title |
ERBB2-CAR-engineered cytokine-induced killer cells exhibit both CAR-mediated and innate immunity against high-risk rhabdomyosarcoma / Michael Merker, Juliane Wagner, Hermann Kreyenberg, Catrin Heim, Laura M. Moser, Winfried S. Wels, Halvard-Björn Bönig, Evelyn Ullrich, Thomas Klingebiel, Peter Bader, Eva Rettinger |
|---|---|
Involved |
Michael Merker (Verfasser)
Juliane Grams (Verfasser) Hermann Kreyenberg (Verfasser) Catrin Heim (Verfasser)
Laura M. Moser (Verfasser)
Winfried S. Wels (Verfasser) Halvard Bönig (Verfasser) Evelyn Ullrich (Verfasser) Thomas Klingebiel (Verfasser) Peter Bader (Verfasser) Eva Rettinger (Verfasser) |
Published |
Frankfurt am Main: Universitätsbibliothek Johann Christian Senckenberg |
Extent |
Online-Ressource |
Language |
|
Country |
|
Topic |
|
Subject |
cellular therapy |
DDC notation |
|
Persistent identifier |
|
Further information |
In: Frontiers in immunology 11.2020, article 581468, doi:10.3389/fimmu.2020.581468, ISSN 1664-3224 |
Record ID |
1223170586 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: